SMEK1 ablation promotes glucose uptake and improves obesity-related metabolic dysfunction via AMPK signaling pathway

Shijun Wei1, Yu Song1, Zhengbin Li1

  • 1Key Laboratory for Experimental Teratology of the Ministry of Education, Department of Medical Genetics, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, People's Republic of China.

Insights

Smek1 protein is linked to obesity and fat cell development. Removing Smek1 protects mice from obesity and improves glucose metabolism, offering a new target for metabolic disease therapies.

Area of Science:

  • Metabolic research
  • Molecular biology
  • Obesity research

Background:

  • Obesity is a significant global health concern.
  • SMEK1, a regulatory subunit of protein phosphatase 4 (PP4), has known metabolic functions in yeast.
  • The role of SMEK1 in mammalian obesity and metabolism was previously unclear.

Purpose of the Study:

  • To investigate the function of SMEK1 in white adipose tissue and glucose uptake in mammals.
  • To determine the correlation between SMEK1 and obesity and related metabolic phenotypes.
  • To elucidate the molecular mechanisms underlying SMEK1's role in adipogenesis and glucose homeostasis.

Main Methods:

  • Analysis of public databases (GWAS, GEPIA, GEO) for SMEK1 correlations.
  • Generation and study of Smek1 knockout (KO) mice.
  • In vitro studies using stromal-vascular fractions (SVFs) and 3T3-L1 cells for adipogenesis and glucose uptake assays (2-NBDG).
  • Pharmacological inhibition of AMPK using Compound C.

Main Results:

  • SMEK1 expression is correlated with obesity and adipogenesis.
  • Smek1 deletion enhanced adipogenesis in cell models.
  • Smek1 KO mice exhibited protection against obesity, insulin resistance, and inflammation, with lower fasting glucose.
  • SMEK1 ablation promoted glucose uptake via increased p-AMPKα(T172) and Glut4 transcription, mediated by PP4 catalytic subunits.

Conclusions:

  • SMEK1 plays a novel role in regulating obesity and glucose homeostasis in mammals.
  • Smek1 deficiency confers protection against metabolic dysfunction.
  • Targeting SMEK1 presents a potential therapeutic strategy for obesity and associated metabolic disorders.

Related Concept Videos

cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.5K
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.6K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.2K